Cargando…
Randomized study of intravesical pirarubicin chemotherapy with low and intermediate-risk nonmuscle-invasive bladder cancer in Japan: Comparison of a single immediate postoperative intravesical instillation with short-term adjuvant intravesical instillations after transurethral resection
PURPOSE: The objective of this study was to evaluate the efficacy, defined by the 3-year tumor recurrence-free survival rate, of intravesical chemotherapy using pirarubicin (THP) in patients with low or intermediate-risk nonmuscle-invasive bladder cancer (NMIBC). PATIENTS AND METHODS: Between Octobe...
Autores principales: | Naya, Yoshio, Mikami, Kazuya, Takaha, Natsuki, Inoue, Yuuta, Fujihara, Atsuko, Kanazawa, Motohiro, Nakanishi, Hiroyuki, Miyashita, Hiroaki, Ukimura, Osamu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211924/ https://www.ncbi.nlm.nih.gov/pubmed/30334959 http://dx.doi.org/10.1097/MD.0000000000012740 |
Ejemplares similares
-
Evaluating the safety of intraoperative instillation of intravesical chemotherapy at the time of nephroureterectomy
por: Moriarty, Michael A., et al.
Publicado: (2015) -
Floating Hydrogel with Self-Generating Micro-Bubbles for Intravesical Instillation
por: Lin, Tingsheng, et al.
Publicado: (2016) -
Reactive Arthritis – A Rare Complication of Intravesical BCG Instillation
por: Freixa, Marta, et al.
Publicado: (2020) -
Intravesical Instillation of Mitomycin C: A Cause of Delayed Bladder Perforation?
por: Penna, Marta, et al.
Publicado: (2012) -
Systemic BCG‐osis following intravesical BCG instillation for bladder carcinoma
por: Liaw, Frank, et al.
Publicado: (2017)